The Growing Market of Solutions Supporting Hospitality’s Comeback

Driven by consumer desires for new experiences, innovative technologies and environmental impacts – travel is changing. Host Sarah Dandashy explores the technologies and logistics that power travel and the brands that build unforgettable experiences.

On this episode of Say Yes To Travel, I talk to Dr. Geoff Trenkle and Lauren Trenkle, PA MPH. I have been interviewing professionals from around the world who have been adapting to stay afloat during the pandemic. This episode is unique because I am talking to folks not directly involved in the hospitality industry, but their work directly impacts the industry.

The duo of Trenkles created Total Testing Solutions, which helps individuals, businesses and families, test for COVID-19. They also help folks adapt to the safety measures out there. This allows those in the industry to test themselves, staff and make sure they get back to doing the work they do in a healthy manner.

The Trenkles started TTS in Los Angeles. But, the need for their testing solutions quickly grew to six locations in California. The inspiration for the idea came during the pandemic. In their practice, things slowed down significantly and then came to a complete halt. They transitioned to telemedicine, but they noticed that essential workers continued to go to work.

They started calling labs to see if they could get swabs to help test. They received five.

“So, it evolved into us trying to network to get any type of test at this point,” Lauren said. They eventually stumbled upon a connection at Rutgers University where they could do saliva tests. They paid for the tests out of pocket because that’s all they could do to be a testing provider for individuals.

They didn’t anticipate this growing into what it did, according to Geoff. It was meant to be a stop-gap to help essential workers around them.

“The reality of how big it really became didn’t really hit us until the big wave in June came about,” Lauren said, “up until then, it was a steady wave we could really manage.”

Once the big waves hit, they struggled because they couldn’t get people in fast enough.

“At one point, we were getting 14,000 calls a day, and we didn’t have the bandwidth to handle that phone call rate,” Geoff said.

That’s when they realized they had something big on their hands, as more people would be getting tested, especially as the world started to open back up.

Listen to learn more about how Total Testing Solutions is helping essential workers in the travel industry get COVID-19 testing.

Say Yes To Travel has a New Episode Every Thursday!

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

 

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More